Axonius Unified Device Observability vs Rapid7 Surface Command: Side-by-Side Comparison (2026)

Axonius Unified Device Observability: Asset visibility & risk mgmt platform for healthcare medical & IT devices. built by Axonius. Core capabilities include Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration..

Rapid7 Surface Command: Attack surface management platform providing continuous asset discovery and monitoring. built by Rapid7. Core capabilities include Continuous asset discovery and monitoring, Internal and external asset inventory, 360-degree attack surface visibility..

Both serve the Cyber Asset Attack Surface Management market but differ in approach, feature depth, and target audience.

Axonius Unified Device Observability differentiates with Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration. Rapid7 Surface Command differentiates with Continuous asset discovery and monitoring, Internal and external asset inventory, 360-degree attack surface visibility.

Axonius Unified Device Observability is developed by Axonius. Rapid7 Surface Command is developed by Rapid7. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Axonius Unified Device Observability and Rapid7 Surface Command serve similar Cyber Asset Attack Surface Management use cases: both are Cyber Asset Attack Surface Management tools. Review the feature comparison above to determine which fits your requirements.